Koers Marinus Pharmaceuticals, Inc. Mexican S.E.
Aandelen
MRNS *
US56854Q2003
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
124 MXN | -2,36% |
|
-.--% | -2,36% |
17/06 | Sectorupdate: Gezondheidszorgaandelen dalen premarket maandag | MT |
17/06 | Top premarket dalers | MT |
Omzet 2024 * | 39,35 mln. 727 mln. 36,81 mln. | Omzet 2025 * | 58,17 mln. 1,07 mld. 54,4 mln. | Marktkapitalisatie | 67,57 mln. 1,25 mld. 63,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -119 mln. -2,2 mld. -111 mln. | Nettowinst (verlies) 2025 * | -78 mln. -1,44 mld. -72,95 mln. | EV/omzet 2024 * | -1,52 x |
Nettoliquiditeiten 2024 * | 127 mln. 2,35 mld. 119 mln. | Nettoliquiditeiten 2025 * | 54,53 mln. 1,01 mld. 51 mln. | EV/omzet 2025 * | 0,22 x |
K/w-verhouding 2024 * |
-0,62
x | K/w-verhouding 2025 * |
-1,18
x | Werknemers | 166 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,86% |
Recentste transcriptie over Marinus Pharmaceuticals, Inc.
1 dag | -2,36% | ||
3 maanden | -2,36% | ||
6 maanden | -2,36% | ||
Lopend jaar | -2,36% |
![Extreem 124](/images/extremecours_fleche.png)
![Extreem 124](/images/extremecours_fleche.png)
![Extreem 83](/images/extremecours_fleche.png)
![Extreem 80](/images/extremecours_fleche.png)
![Extreem 80](/images/extremecours_fleche.png)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12-04-21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01-12-08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05-09-18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12-12-19 |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,95% | 819 mld. | |
+43,62% | 638 mld. | |
-6,98% | 351 mld. | |
+19,08% | 329 mld. | |
+9,05% | 298 mld. | |
+16,30% | 242 mld. | |
+2,41% | 225 mld. | |
+12,47% | 217 mld. | |
+8,91% | 168 mld. |
- Beurs
- Aandelen
- Koers MRNS
- Koers MRNS *